Bank of America’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,510
| Closed | -$39.9K | – | 5777 |
|
|
2025
Q4 | $39.9K | Sell |
4,510
-5,835
| -56% | -$73.8K | ﹤0.01% | 5900 |
|
|
2025
Q3 | $135K | Buy |
10,345
+3,705
| +56% | +$45.8K | ﹤0.01% | 6465 |
|
|
2025
Q2 | $82.7K | Buy |
6,640
+2,375
| +56% | +$28.4K | ﹤0.01% | 6612 |
|
|
2025
Q1 | $43K | Sell |
4,265
-3,167
| -43% | -$38.5K | ﹤0.01% | 6789 |
|
|
2024
Q4 | $105K | Buy |
7,432
+2,521
| +51% | +$49.2K | ﹤0.01% | 6375 |
|
|
2024
Q3 | $112K | Sell |
4,911
-2,134
| -30% | -$43.1K | ﹤0.01% | 6280 |
|
|
2024
Q2 | $126K | Buy |
7,045
+1,716
| +32% | +$38K | ﹤0.01% | 6138 |
|
|
2024
Q1 | $144K | Buy |
5,329
+5,188
| +3,679% | +$83.3K | ﹤0.01% | 6055 |
|
|
2023
Q4 | $1.86K | Buy |
141
+11
| +8% | +$119 | ﹤0.01% | 7136 |
|
|
2023
Q3 | $1.44K | Buy |
130
+10
| +8% | +$145 | ﹤0.01% | 7188 |
|
|
2023
Q2 | $2.27K | Sell |
120
-169
| -58% | -$2.05K | ﹤0.01% | 7123 |
|
|
2023
Q1 | $3.13K | Sell |
289
-2,381
| -89% | -$26.6K | ﹤0.01% | 7153 |
|
|
2022
Q4 | $21.1K | Buy |
+2,670
| New | +$30.7K | ﹤0.01% | 6718 |
|
|
2022
Q3 | – | Sell |
-3
| Closed | -$44 | – | 7815 |
|
|
2022
Q2 | $0 | Sell |
3
-3,187
| -100% | -$50.2K | ﹤0.01% | 7994 |
|
|
2022
Q1 | $60K | Sell |
3,190
-5,333
| -63% | -$108K | ﹤0.01% | 7092 |
|
|
2021
Q4 | $205K | Buy |
8,523
+2,409
| +39% | +$88.2K | ﹤0.01% | 6483 |
|
|
2021
Q3 | $298K | Buy |
6,114
+859
| +16% | +$50K | ﹤0.01% | 6011 |
|
|
2021
Q2 | $498K | Buy |
+5,255
| New | +$278K | ﹤0.01% | 5431 |
|
|
2019
Q4 | – | Sell |
-5
| Closed | – | – | 7066 |
|
|
2019
Q3 | $0 | Buy |
+5
| New | +$158 | ﹤0.01% | 7246 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | – | – | 7091 |
|
|
2018
Q3 | $0 | Buy |
+11
| New | +$359 | ﹤0.01% | 7251 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7072 |
|
|
2018
Q1 | – | Sell |
-7
| Closed | – | – | 7088 |
|
|
2017
Q4 | $0 | Buy |
+7
| New | +$509 | ﹤0.01% | 7018 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | – | – | 6954 |
|
|
2016
Q4 | $0 | Buy |
+1
| New | +$312 | ﹤0.01% | 7023 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7094 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7111 |
|
|
2014
Q4 | – | Hold |
0
| – | -$1K | – | 7668 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 7867 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7776 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 7871 |
|
Other funds holding ATOS
VCM
VFT
Bank of America's ATOS Position: Q1 2026 in Review
Bank of America sold out of Atossa Therapeutics (ATOS) in Q1 2026, closing a stake of 4,510 shares — an estimated $39.9K sold.
Bank of America first reported a position in ATOS in Q4 2016 and held it in 22 quarters. The position peaked at $498K in Q2 2021. 33 funds tracked by Wall St. Rank hold ATOS as of Q1 2026.
- Bank of America reported no remaining Atossa Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 4,510 Atossa Therapeutics shares in Q1 2026, an estimated $39.9K.
- Bank of America first reported a position in Atossa Therapeutics in Q4 2016 and held it in 22 quarters.
- Bank of America's Atossa Therapeutics position peaked at $498K in Q2 2021.
- 33 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.